Corporate Partnership

Life Science Cares is a powerful partner in your company’s commitment to enacting positive social change. Companies are recognizing, more than ever, the importance of supporting community-based efforts that align with employee values, ignite engagement and work toward solutions for complex issues like poverty, racism, and economic inequity.

As a Corporate Partner, you can better understand community needs and forge relationships with a variety of local nonprofit organizations. Life Science Cares connects and maintains relationships for you with a variety of high impact nonprofit partners in the communities we live and work.

Regardless of the size or structure of your internal corporate social responsibility program, the collective power of Life Science Cares will amplify your philanthropic community-based outreach and engagement.

 

Learn more about Corporate Partnership. 

Corporate Partner Resources and Tools for Impact
We support your corporate responsibility efforts with a suite of tools, resources and events to inspire employee volunteer engagement and impact.
• The opportunity to connect and develop meaningful relationships with nonprofit partners in your community who have been vetted by Life Science Cares.
• Access for your employees to a variety of virtual and in-person volunteer opportunities throughout the year.
• Toolkits, collateral, social media posts to share with employees and other stakeholders highlighting your commitment to Life Science Cares and to making a positive change in your community.
• Acknowledgement on Life Science Cares’ website, blog, social media channels and monthly newsletters.
• Complimentary access to Life Science Cares Mixers, educational programming and networking events.
• Priority access to registration and sponsorship of Life Science Cares’ Signature Events.

 

THANK YOU TO LIFE SCIENCE CARES
CORPORATE PARTNERS!

FILTER BY

5AM Ventures
89bio
AbbVie
Acadia
Actio Biosciences INC.
Aera Therapeutics
Alexandria Real Estate Equities
Alexion
Alkeus
Allay Therapeutics
Alnylam
Alterome Therapeutics
AN2 Therapeutics
Anaptys Bio, Inc
Annexon Biosciences
Apogee Therapeutics
Arbor Bio
Archer Insights
Architect Therapeutics
Arcturus Therapeutics
Ardelyx
Arrowhead Pharmaceuticals
Aspen Neuroscience
Atomwise
aTyr Pharma
Aura Biosciences
Autobahn Therapeutics, Inc
Avalyn Pharma
Avidity Biosciences
B+Labs
Beam Therapeutics
Belharra Therapeutics
Bicara
BioAnalysis
BioAtla
Biocom California
Biogen
BioMarin
BioPhase Solutions
Bitterroot Bio
Boundless Bio
Bowdoin Group
Breakthrough Properties
Bridge Bank
C4 Therapeutics
Cabaletta Bio
CAMP4 Therapeutics
Cantor Fitzgerald
Capital Advisors
CBRE
Century Therapeutics
CFGI
Christopher Weil & Company
CIC Philadelphia
Citrin Cooperman
City Therapeutics
Claria Partners
Collegium Pharmaceutical
Context
Contineum Therapeutics
Cooley
Corval
Crowe
Cullinan Oncology
Cytokinetics
Danforth Advisors
DCF Group
Deerfield Group
Definium Therapeutics
Deloitte
Delphia Therapeutics
Denali Therapeutics
Dispatch Bio
Draig Therapeutics
Dynavax Technologies
Dyne
EDC NYC
Editas Medicine
Eli Lilly
Emerald Bioventures
Endeavor Biomedicines
enGene
Entrada Therapeutics
Envisagenics
Erasca, Inc.
Evercore
Evoke Canale
Exelixis
EyePoint Pharmaceuticals
Flagship Pioneering
Foundation Medicine
Freshfields
Genentech
General Atlantic Foundation
Gilead Foundation
Global Blood Therapeutics
Goodwin Procter LLP
Gossamer Bio
Grail
Guardant Health
Halloran Consulting Group
Harmony BioSciences
Havas San Francisco
Healthpeak Properties
Hercules Capital
Higher Medicine
Hologic
Inception Therapeutics
Innoviva
Invivyd
Ionis Pharmaceuticals
Ipsen Biopharmaceuticals
IRRAS AB
J.P. Morgan
Jazz Pharmaceuticals
Jeito
Jnana Therapeutics
Johnson & Johnson Innovation
Kailera Therapeutics
Kate Therapeutics
Kiniksa Pharmaceuticals
KPMG
Kura Oncology, Inc
Kymera Therapeutic
LaVoie Health Science
LEXEO Therapeutics
Life Sciences PA
Light Horse Therapeutics
Locanabio, Inc
Longboard Pharmaceuticals
Lyell Immunopharma
Madrigal Pharmaceuticals
Maeve Solutions
Marsh McLennan Agency
Mass. Life Sciences Center
MassBio
MassMEDIC
Merck
Merida Biosciences
Metaphore Bio
Minaris
Mirador Therapeutics
Mirum Pharmaceuticals
Neomorph
Neumora
Neurelis
Nkarta
Novo Nordisk
Novocure
Nurix Therapeutics
NYSE
Omega Funds
OmniAb Inc
Pacira
PAR Clinical
Paragon
Paratek Pharmaceuticals
Passage Bio
Pfizer
Pharmakon
PJT Partners
Pliant Therapeutics
Procopio
Protara Therapeutics
Pulse Biosciences
PwC
Q32 Bio
Rain Oncology
Rapport Therapeutics
Real Chemistry
Recludix Pharma
Roivant Sciences
Royalty Pharma
Russell Reynolds Associates
Russo Partners LLC
Sam Brown Healthcare Communications
Sangamo Therapeutics
Sanofi
Savills
Schrodinger
Scilex Holding Company
SciSure
Seagen
Seaport Therapeutics
SERB Pharmaceuticals
SMAC
Sofinnova
Sutro Biopharma
Syndax Pharmaceuticals, Inc
Taiho Oncology
Terremoto Biosciences
The NemetzGroup
Thermo Fisher Scientific
Third Harmonic Bio
Third Rock Ventures
Trinity Life Sciences
Triumvirate
Twist Bioscience
Unicycive Therapeutics Inc.
UniQure
Upstream Bio
Valo Health
van den Boom & Associates
Vertex Pharmaceuticals
Vir Biotechnology, Inc.
Viracta Therapeutics
Viridian
Vividion Therapeutics
Voyager Therapeutics
Wave Life Sciences
WilmerHale
Xenon Pharmaceuticals
Xilio Therapeutics
Zageno
Zogenix
Load More